@Tizard still pretty lazy to tell someone to 'invest elsewhere'...

@Tizard still pretty lazy to tell someone to 'invest elsewhere' rather than try to help educate them on the merits or pitfalls of investing in a company. luckily my example was hypothetical, maybe something like 'if you dont like it here, go back to where you came from' is a better corollary.

in any case, i have been saying for a while AXE is a moonshot. this could go back to 10-20c and one day turn around and announce they've made a major scientific breakthrough and immediately 3-4x. we just don't know, and i think that lack of understanding the timing and where they are at in the road to commercialisation is part of the problem. but also it's likely that AXE don't know how it will play out either, so they can't announce any firm timeframes because they have zero idea if they can hit them or not. my personal view is that 12cq is still over a decade away from commercialisation (if at all) and the biosensor maybe 5-10 years. this is a small australian company playing in a niche space dominated by huge companies with huge amounts of money. the overall likelihood for success is low and people have to be realistic about the prospect of success (only put in what you can afford to lose) and the potential for this to keep dropping.